首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.
【24h】

Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.

机译:合成新系列的1-芳基-1,4-二氢-4-氧代-6-甲基哒嗪-3-羧酸作为潜在的抗菌剂。

获取原文
获取原文并翻译 | 示例
           

摘要

New series of 1-aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid has been synthesized and the structures of the new compounds were established on the basis of 1H-NMR, mass (ES/MS), elemental analysis and IR spectral data. In vitro antibacterial activity (MIC activity) was evaluated and compared with standard drugs ciprofloxacin, sparfloxacin and trovafloxacin. Most of the compounds in the series have shown very interesting antibacterial activity against both gram-positive and gram-negative organisms. In this paper, we describe studies leading to identification of antibacterial agents incorporating novel pyridazine ring surrogate. In a gratifying result, the initial pyridazine-3-carboxylic acid analogues prepared were found to exhibit in vitro antibacterial activity approaching that of corresponding fluoroquinolone progenitor.
机译:合成了一系列新的1-芳基-1,4-二氢-4-氧代-6-甲基哒嗪-3-羧酸,并基于1H-NMR,质量(ES / MS),元素分析和红外光谱数据。评估了体外抗菌活性(MIC活性),并将其与标准药物环丙沙星,司巴沙星和曲伐沙星进行了比较。该系列中的大多数化合物对革兰氏阳性和革兰氏阴性生物均显示出非常有趣的抗菌活性。在本文中,我们描述了导致鉴定结合新型哒嗪环替代物的抗菌剂的研究。令人欣慰的是,发现制备的最初的哒嗪-3-羧酸类似物在体外的抗菌活性接近相应的氟喹诺酮祖细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号